Ignite Creation Date:
2024-05-06 @ 4:02 AM
Last Modification Date:
2024-10-26 @ 11:42 AM
Study NCT ID:
NCT02439736
Status:
COMPLETED
Last Update Posted:
2017-08-08
First Post:
2015-05-07
Brief Title:
EVALUATION OF BIOMARKERS OF TRAUMATIC BRAIN INJURY EXTENSION STUDY
Sponsor:
Banyan Biomarkers Inc
Organization:
Banyan Biomarkers Inc
Study Overview
Official Title:
A PROSPECTIVE CLINICAL EVALUATION OF BIOMARKERS OF TRAUMATIC BRAIN INJURY EXTENSION STUDY
Status:
COMPLETED
Status Verified Date:
2017-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ALERT-TBIx
Brief Summary:
The primary objective of this study is to evaluate Ubiquitin C-terminal Hydrolase-L1 UCH-L1 and Glial Fibrillary Acidic Protein GFAP biomarker levels in a population of CT-positive subjects as determined by an independent Neuroimaging Review Committee presenting acutely with traumatic brain injury Glasgow Coma Scale score 9-15
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None